Literature DB >> 8864145

Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey.

R C Kessler1, C B Nelson, K A McGonagle, J Liu, M Swartz, D G Blazer.   

Abstract

General population data are presented on the prevalence and correlates of comorbidity between DSM-III-R major depressive disorder (MDD) and other DSM-III-R disorders. The data come from the US National Comorbidity Survey, a large general population survey of persons aged 15-54 years in the non-institutionalised civilian population. Diagnoses are based on a modified version of the Composite International Diagnostic Interview (CIDI). The analysis shows that most cases of lifetime MDD are secondary. In the sense that they occur in people with a prior history of another DSM-III-R disorder. Anxiety disorders are the most common primary disorders. The time-lagged effects of most primary disorders on the risk of subsequent MDD continue for many years without change in magnitude. Secondary MDD is, in general, more persistent and severe than pure or primary MDD. This has special public health significance because lifetime prevalence of secondary MDD has increased in recent cohorts, while the prevalence of pure and primary depression has remained unchanged.

Entities:  

Mesh:

Year:  1996        PMID: 8864145

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


  186 in total

1.  What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression?

Authors:  Jackie K Gollan; Maurizio Fava; Benji Kurian; Stephen R Wisniewski; A John Rush; Ella Daly; Sachiko Miyahara; Madhukar H Trivedi
Journal:  Depress Anxiety       Date:  2011-12-06       Impact factor: 6.505

2.  Alcohol induced depressive-like behavior is associated with a reduction in hippocampal BDNF.

Authors:  Sheketha R Hauser; Bruk Getachew; Robert E Taylor; Yousef Tizabi
Journal:  Pharmacol Biochem Behav       Date:  2011-09-10       Impact factor: 3.533

3.  Regulatory Focus and Anxiety: A Self-Regulatory Model of GAD-Depression Comorbidity.

Authors:  Megan M Klenk; Timothy J Strauman; E Tory Higgins
Journal:  Pers Individ Dif       Date:  2011-05-01

4.  Depression and the risk of psoriasis in US women.

Authors:  P L Dominguez; J Han; T Li; A Ascherio; A A Qureshi
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-10-03       Impact factor: 6.166

5.  Value-Based Benefit Design to Improve Medication Adherence for Employees with Anxiety or Depression.

Authors:  Kimberly J Reid; Kathleen M Aguilar; Eric Thompson; Ross M Miller
Journal:  Am Health Drug Benefits       Date:  2015 Jul-Aug

6.  Relationships among independent major depressions, alcohol use, and other substance use and related problems over 30 years in 397 families.

Authors:  Marc A Schuckit; Tom L Smith; Jelger Kalmijn
Journal:  J Stud Alcohol Drugs       Date:  2013-03       Impact factor: 2.582

7.  Primary care patients with depression are less accepting of treatment than those seen by mental health specialists.

Authors:  Benjamin W Van Voorhees; Lisa A Cooper; Kathryn M Rost; Paul Nutting; Lisa V Rubenstein; Lisa Meredith; Nae-Yuh Wang; Daniel E Ford
Journal:  J Gen Intern Med       Date:  2003-12       Impact factor: 5.128

8.  Effective Recognition and Treatment of Generalized Anxiety Disorder in Primary Care.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2004

9.  The Hospital Anxiety and Depression Scale in Greek cancer patients: psychometric analyses and applicability.

Authors:  Kyriaki Mystakidou; Eleni Tsilika; Efi Parpa; Emmanuela Katsouda; Antonis Galanos; Lambros Vlahos
Journal:  Support Care Cancer       Date:  2004-10-06       Impact factor: 3.603

10.  Psychometric properties of an automated telephone-based PHQ-9.

Authors:  Ramesh Farzanfar; Timothy Hereen; Joseph Fava; Jillian Davis; Louis Vachon; Robert Friedman
Journal:  Telemed J E Health       Date:  2013-11-12       Impact factor: 3.536

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.